SS Innovations International, Inc. is a medical robotics company, which develops a fully autonomous medical robotic system using proprietary software. The company is headquartered in Fort Lauderdale, Florida and currently employs 378 full-time employees. The company went IPO on 2018-07-09. The Company’s product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery. The SSi Mantra Surgical Robotic System is designed to enable surgeons to perform a wide range of surgical procedures including cardiovascular, thoracic, head and neck, gynecological, urological, cancer and general surgeries. The SSi Mantra 3 is comprised of components, such as Surgeon Console, Patient-Side Robotic Arm Carts, and Vision Cart. Its instruments under development include NADI-Automated Coronary Anastomotic Connector, SSi Multi-Fire Clip Applier, SSi Ultrasonic Surgical Device, SSi Maya-XR Pre-Operative Simulator, SSi Holographic Anatomy, SSi Yog-Tele Proctor, SSi Chitrasa-Advanced DICOM Viewer and SSi Mixed Reality Headset.
SSII stock price ended at $4.76 on 星期一, after rising 6.73%
On the latest trading day Mar 16, 2026, the stock price of SSII rose by 6.73%, climbing from $4.62 to $4.76. Throughout the session, the stock experienced a volatility of 5.22%, with prices fluctuating between a daily low of $4.60 and a high of $4.84. Alongside this price increase, trading volume also rose by 140.1K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 32.3K shares were traded, amounting to a market value of approximately $921.6M.